A multicentre single arm phase II trial assessing the efficacy of radical immunotherapy and chemotherapy, stereotactic radiotherapy and surgery in patients with synchronous oligo-metastatic NSCLC

ETOP CHESS

Coordinating investigator

Rolf A. Stahel
Prof. Dr. med.
Rolf A.
Stahel
Universitätsspital Zürich
+41 44 634 28 71

For further information on the trial please consult the ETOP website: www.etop-eu.org.

Clinics

All trials

More trials: Lung cancer

Registry and study of EGFR-mutated NSCLC
SAKK LuCa 2
Phase III randomized controlled trial comparing maintenance systemic therapy alone with systemic therapy plus local ablative treatment for patients with advanced stage IV non-small cell lung cancer
salVage
Immunotherapy and radiotherapy in stage III non-small cell lung cancer
SAKK 16/18